Stephen Morlock, Director at BioPharmX Corp (BPMX), bought 6,000 shares at $1.43 ($9K) on 2016-01-11, disclosed to the SEC on 2016-01-12.
Open-market purchase of $9k BPMX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.43 | 3,000 | $4K | 46.7% |
| 2 | $1.63 | 3,000 | $5K | 53.3% |
| Total | $1.53 avg | 6,000 | $9K | 100% |
| Filing → |
| BPMX | BUY | 2016-11-29 | $150K | — | Filing → |
| BPMX | BUY | 2016-01-15 | $18K | — | Filing → |
| BPMX | BUY | 2016-01-11 | $7K | — | Filing → |